Medium-term comprehensive outcomes of heart transplantation using donors with hepatitis C viremia to aviremic recipients
Patient and graft survival rates do not differ between D+ and D- heart transplant recipients. There is no difference in post-transplant complications, including MACE, rejection, CAV, FCH, and extrahepatic manifestations of HCV. These findings suggest medium-term safety in utilizing D+ hearts for enlarging the pool of limited organs.
Authors
- Qijun Yang (ORCID: https://orcid.org/0009-0007-3874-1399)
- G. André Ng (ORCID: https://orcid.org/0000-0001-5965-0671)
- Omar T. Sims (ORCID: https://orcid.org/0000-0002-3207-2231)
- Ritika Mazumder (ORCID: https://orcid.org/0009-0004-9875-6849)
- Sakthi Surya Prakash (ORCID: https://orcid.org/0000-0001-9287-3180)
- Sarah Khan
- William D. Carey
Institutions
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
Publication Details
- Journal
- JHLT Open
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1016/j.jhlto.2025.100467
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00